Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06162897 · ClinicalTrials.gov registry record · NA

Case Management Dyad

A NA study of HIV and Pre-exposure Prophylaxis, sponsored by University of Chicago.

Recruiting
Registry status
NA
Development phase
180
Enrollment target
1
Study location

NCT06162897 is a NA study of HIV and Pre-exposure Prophylaxis that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 180 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06162897, a NA study of HIV and Pre-exposure Prophylaxis, is actively recruiting participants, sponsored by University of Chicago.

RECRUITING
Registry status
NA
Development phase
180 participants
Enrollment target
1
Study location

Study Summary

The overall goal of this study is to test whether dyadic and focused case management will (1) improve financial wellbeing, (2) improve access to food, (3) increase linkage and retention rates for individuals living with HIV or those taking PrEP (PrEP persistence), and (4) increase the proportion of individuals living with HIV who are virally suppressed (viral suppression) when compared to routine Ryan White Non-Medical Case Management.

Interventions

  • BEHAVIORAL Dyadic Case Management

Study Locations (1)

Illinois

  • University of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2022-09-09
Est. Completion 2027-06-30
Phase NA

Sponsor

University of Chicago

796 total trials

What the Registry Record Tells You About NCT06162897

The ClinicalTrials.gov registry entry for NCT06162897 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 439-participant average among 303 other HIV trials with a reported enrollment target (59% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with HIV appearing as the primary indexed condition, and to 1 intervention - of which Dyadic Case Management is the first listed.

NCT06162897 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06162897 about?

NCT06162897 is a clinical study titled "Case Management Dyad". The overall goal of this study is to test whether dyadic and focused case management will (1) improve financial wellbeing, (2) improve access to food, (3) increase linkage and retention rates for individuals living with HIV or those taking PrEP (PrEP persistence), and (4) increase the proportion of ...

What is the current status of trial NCT06162897?

This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2022-09-09. Estimated completion is 2027-06-30.

What conditions does trial NCT06162897 study?

This clinical trial studies the following conditions: HIV, Pre-exposure Prophylaxis, Case Management.

What interventions are being tested in trial NCT06162897?

The interventions under investigation include: Dyadic Case Management (BEHAVIORAL).

Who is sponsoring clinical trial NCT06162897?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06162897 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.